Trends-in-MedicineLynne Peterson,
Senior Writer
Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter.
Copyright© 2004
No articles may be reproduced without written permission of the publisher.
Return Home
American Academy of Cosmetic Surgery
Summary: The cosmetic market for Allergan’s Botox is still growing, and new dermal fillers are unlikely to affect Botox use, either positively or negatively. Botox pricing is very competitive, and patients are shopping price. Inamed’s Dysport is likely to be a viable competitor to Botox. Doctors were surprised and discouraged by the FDA’s delay in approving silicone breast implants, but they and their patients are satisfied with saline implants. Medicis’ Restylane has gotten off to a good start. Doctors who have already started using it are pleased with the results. Restylane is expected to take significant market share from collagen implants while also expanding the market but not affect Botox use. In dermal fillers, there is little excitement over Inamed’s Hylaform or Juvederm or Artes Medical’s Artecoll, but BioForm’s Radiance is generating interest and off-label usage.
American Academy of Dermatology
Summary: Biologic agents to treat psoriasis generated a lot of interest at this meeting. There were numerous sessions every day on biologics, and each was packed. Dermatologists clearly wanted to know more about all of these agents, but it is Amgen’s Enbrel that is taking off strongest. The data on Allergan’s oral tazarotene (page 8) looked good, and when it is FDA-approved, this agent will cause some doctors to delay use of biologics. There was no significant new data on Novartis’s oral pimecrolimus (page 11), but the drug will start Phase III trials later this year. There also was new information presented in several other areas of dermatology, including topical agents for psoriasis and other conditions (page 11), dermal fillers (page 12), botulinum toxin (page 14), and melanoma (page 15).
1879 Avenida Dracaena, Jensen Beach, FL, 34957, 772-334-7409, Fax 772-334-0856
Email webmaster about site: snyderk577@aol.com
